Seeing Is Believing

Currently out of the existing stock ratings of Steve Silver, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst Steve Silver, currently employed at ARGUS, carries an average stock price target met ratio of 50% that have a potential upside of 42% achieved within 204 days.
Steve Silver’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CVS, CVS Health Corp at 19-Aug-2026.
Analyst best performing recommendations are on SILK (SILK ROAD MEDICAL).
The best stock recommendation documented was for SILK (SILK ROAD MEDICAL) at 3/7/2024. The price target of $24 was fulfilled within 103 days with a profit of $8.02 (50.19%) receiving and performance score of 4.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2026
$115
$30.89 (36.73%)
$67
7 days ago
(07-Oct-2026)
10/14 (71.43%)
$30.7 (36.42%)
68
Buy Since 16-Jun-2025
$102
$17.89 (21.27%)
$93
26 days ago
(18-Sep-2026)
4/8 (50%)
$12.65 (14.16%)
180
Buy Since 21-Jul-2021
$95
$10.89 (12.95%)
$95
26 days ago
(18-Sep-2026)
9/13 (69.23%)
$5.65 (6.32%)
159
Buy Since 21-Aug-2025
$96
$11.89 (14.14%)
$90
2 months 10 days ago
(04-Aug-2026)
1/3 (33.33%)
$9.06 (10.42%)
278
Buy Since 11-May-2026
$82
$-2.11 (-2.51%)
$77
2 months 13 days ago
(31-Jul-2026)
3/4 (75%)
$-1.45 (-1.74%)
26
Which stock is Steve Silver most bullish on?
Which stock is Steve Silver most reserved on?
What Year was the first public recommendation made by Steve Silver?